ISRG
Get informed when a big investor buys or sells
+ FollowApril 21, 2026 - AI Summary
Overvalued by 67.9% based on the discounted cash flow analysis.
| Market cap | $150.39 Billion |
|---|---|
| Enterprise Value | $143.08 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $8 |
| Beta | 1.51 |
| Outstanding Shares | 354,900,000 |
| P/E Ratio | 50.59 |
|---|---|
| PEG | 287 |
| Price to Sales | 14.04 |
| Price to Book Ratio | 8.31 |
| Enterprise Value to Revenue | 13.52 |
| Enterprise Value to EBIT | 40.9 |
| Enterprise Value to Net Income | 48 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.04 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 1.1163▼ 14.69% |
|---|---|
| Total Calls | 2,849,489▼ 10.44% |
| Total Puts | 3,180,897▼ 20.86% |
Holdings and activity of institutional investors.
| Ownership % | 82.39%▼ 1.83% |
|---|---|
| Total Invested | $135.05B▼ 20.00% |
| Investors Holding | 2,374▼ 115.00% |
No data
This committee directly influences the development and analysis of tax legislation, providing crucial revenue estimates. Its work directly impacts corporate tax structures and the overall tax burden on companies like Intuitive Surgical.
This powerful committee controls taxation, trade, and entitlement spending. Medicare and Medicaid reimbursement policies are critical for healthcare providers and, by extension, medical device manufacturers. Tax policy directly impacts ISRG's profitability.
This committee directly allocates federal spending. Its subcommittees determine funding for healthcare programs (e.g., NIH, VA) and scientific research, which directly impacts the market and R&D opportunities for medical device manufacturers like ISRG.
This committee regulates the FDA, which is the primary approval body for medical devices. Its oversight of NIH funding impacts medical research, and labor laws affect manufacturing costs, all directly critical to ISRG's business.
This committee's oversight of intellectual property laws is crucial for ISRG, which relies heavily on patents for its surgical robotics. Its antitrust jurisdiction can also influence M&A and market competition within the medical device industry.
As a manufacturer of surgical instruments, ISRG's products are likely used in VA hospitals. The committee's funding decisions directly impact government healthcare contractors and medical device procurement for veterans.